Xperi Announces Event with the Financial Community
Get Alerts XPER Hot Sheet
Join SI Premium – FREE
SAN JOSE, Calif.--(BUSINESS WIRE)-- Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary experiences, will participate in the following event with the financial community.
Stephens Annual Investment Conference
November 16, 2023
Webcast: 10:00 a.m. ET / 7:00 a.m. PT
Jon Kirchner, Chief Executive Officer
Robert Andersen, Chief Financial Officer
The Stephens fireside chat will be webcast. Interested parties can access the event on Xperi’s Investor Relations website at investor.xperi.com.
About Xperi Inc.
Xperi invents, develops, and delivers technologies that enable extraordinary experiences. Xperi technologies, delivered via its brands (DTS®, HD Radio™, TiVo®), and by its startup, Perceive, and IMAX Enhanced®, an IMAX and DTS partnership, are integrated into billions of consumer devices and media platforms worldwide, powering smart devices, connected cars and entertainment experiences. Xperi has created a unified ecosystem that reaches highly engaged consumers, driving increased value for partners and customers.
Xperi, DTS, HD Radio, Perceive, TiVo, and their respective logos are trademarks or registered trademarks of Xperi Inc. or affiliated companies in the United States and other countries. All other company, brand and product names may be trademarks or registered trademarks of their respective companies.
SOURCE: Xperi Inc.
XPER-E
View source version on businesswire.com: https://www.businesswire.com/news/home/20231101992889/en/
Xperi Investor Contact:
Mike Iburg, VP, Investor Relations
+1 408-321-3827
[email protected]
Xperi Media Contact:
Amy Brennan, Senior Director, Corporate Communications
+1 949-518-6846
[email protected]
Source: Xperi Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AULUMU Brings Award-Winning High-Performance Gear to IFA 2026 in Berlin
- Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis
- Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share